These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22781431)

  • 1. Researchers hope new database becomes universal cancer genomics tool.
    Martin M
    J Natl Cancer Inst; 2012 Jul; 104(14):1045-7. PubMed ID: 22781431
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomics centers. Disease gene research heats up in the desert.
    Jensen MN
    Science; 2002 Jul; 297(5578):29-30. PubMed ID: 12098677
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene expression and cancer: getting it together.
    Nat Genet; 2002 May; 31(1):1-2. PubMed ID: 11984554
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional genomics: improving cancer prognosis and drug development.
    Mariani SM
    MedGenMed; 2003 Mar; 5(1):18. PubMed ID: 12827079
    [No Abstract]   [Full Text] [Related]  

  • 5. ROCK: a breast cancer functional genomics resource.
    Sims D; Bursteinas B; Gao Q; Jain E; MacKay A; Mitsopoulos C; Zvelebil M
    Breast Cancer Res Treat; 2010 Nov; 124(2):567-72. PubMed ID: 20563840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].
    Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G
    Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer gene microarrays pass muster.
    Twombly R
    J Natl Cancer Inst; 2006 Oct; 98(20):1438-40. PubMed ID: 17047189
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploring the human genome in cancer with genomic approaches.
    Scheel JR; Kuo MD
    J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971
    [No Abstract]   [Full Text] [Related]  

  • 9. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
    Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
    Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic strategies for personalized cancer therapy.
    Garman KS; Nevins JR; Potti A
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclins and related kinases in cancer cells.
    Malumbres M
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic profiling can predict chemotherapy side effects and treatment response.
    Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
    [No Abstract]   [Full Text] [Related]  

  • 13. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression genomics and cancer biology.
    Liu ET
    Pharmacogenomics; 2004 Dec; 5(8):1117-28. PubMed ID: 15584878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevant genomics of neurotensin receptor in cancer.
    Elek J; Pinzon W; Park KH; Narayanan R
    Anticancer Res; 2000; 20(1A):53-8. PubMed ID: 10769634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles as an additional tool to conventional predictive factors to assist in management of early endocrine responsive breast cancer.
    Chow LW
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S13-7. PubMed ID: 20374025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational prediction of cancer-gene function.
    Hu P; Bader G; Wigle DA; Emili A
    Nat Rev Cancer; 2007 Jan; 7(1):23-34. PubMed ID: 17167517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer.
    Baggerly KA; Coombes KR; Neeley ES
    J Clin Oncol; 2008 Mar; 26(7):1186-7; author reply 1187-8. PubMed ID: 18309960
    [No Abstract]   [Full Text] [Related]  

  • 19. A gene expression database for the molecular pharmacology of cancer.
    Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
    Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model.
    Nakagawara A; Ohira M
    Cancer Lett; 2004 Feb; 204(2):213-24. PubMed ID: 15013220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.